Skip to content

Intelligent exploration of AI-assisted nutritional risk early warning and full-process precise Management for Patients with digestive tract tumors

Intelligent exploration of AI-assisted nutritional risk early warning and full-process precise Management for Patients with digestive tract tumors

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119624
Enrollment
Unknown
Registered
2026-03-01
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive Tract Tumors

Interventions

Intervention Group:Full digital symptom management with dietary and exercise guidance and intervention based on platform data

Sponsors

Lanzhou University Second Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Pathologically confirmed esophageal/gastric/colorectal/liver cancer/gallbladder cancer/pancreatic cancer/biliary malignancies; 2. Expected survival period >=3 months; 3. Possess the ability to use Internet of Things (iot) devices.

Exclusion criteria

Exclusion criteria: 1. Non-gastrointestinal primary tumors; 2. Pregnant and lactating patients; 3. Patients with chronic intestinal inflammatory diseases; 4. Patients with cognitive dysfunction who cannot cooperate to complete the follow-up; 5. Patients considered unsuitable for inclusion by the researchers.

Design outcomes

Primary

MeasureTime frame
Survival after anti-tumor treatment (including recurrence-free survival and overall survival);Quality of life score;

Secondary

MeasureTime frame
Nutritional assessment indicators (including nutritional risk screening, daily nutrient intake, PG-SGA results, body weight, waist circumference, calf circumference);Body composition analysis indicators (including limb skeletal muscle mass index, body fat percentage, phase angle);Physical performance indicators (including non-dominant/injured hand grip strength, grip strength-to-body weight index, BMI change, 6-meter walk test);Medical diagnosis and treatment information (including tumor type, malignancy grade, anti-tumor treatment modality);Laboratory examination indicators (including nutrition-related blood parameters, liver function, inflammatory markers);Symptom control status;

Countries

China

Contacts

Public ContactZhang Shuze

Lanzhou University Second Hospital

zhangshuze_07@126.com+86 181 8969 3537

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026